Ken Griffin’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$81.8M Buy
265,420
+230,053
+650% +$71.3M 0.01% 1130
2026
Q2
$9.9M Sell
35,367
-35,972
-50% -$9.46M ﹤0.01% 3588
2026
Q1
$19M Sell
71,339
-76,957
-52% -$20.8M ﹤0.01% 2393
2025
Q4
$37.2M Sell
148,296
-368,258
-71% -$97.8M 0.01% 1700
2025
Q3
$148M Buy
516,554
+376,298
+268% +$101M 0.02% 626
2025
Q2
$36.8M Buy
140,256
+137,948
+5,977% +$33.6M 0.01% 1495
2025
Q1
$537K Sell
2,308
-1,428,113
-100% -$347M ﹤0.01% 8313
2024
Q4
$328M Buy
1,430,421
+1,296,573
+969% +$297M 0.06% 242
2024
Q3
$29.9M Buy
+133,848
New +$29.4M 0.01% 1685
2024
Q2
– Sell
-351,724
Closed -$71.5M – 14934
2024
Q1
$76.8M Sell
351,724
-143,300
-29% -$31.6M 0.01% 892
2023
Q4
$113M Buy
495,024
+366,335
+285% +$77M 0.02% 617
2023
Q3
$25.9M Buy
128,689
+79,116
+160% +$16.7M 0.01% 1618
2023
Q2
$12M Sell
49,573
-325,873
-87% -$73.6M ﹤0.01% 2447
2023
Q1
$86.1M Buy
375,446
+243,278
+184% +$58.3M 0.02% 704
2022
Q4
$31.1M Sell
132,168
-44,749
-25% -$10.2M 0.01% 1523
2022
Q3
$36.2M Sell
176,917
-331,664
-65% -$79M 0.01% 1318
2022
Q2
$119M Buy
508,581
+197,612
+64% +$49M 0.03% 482
2022
Q1
$82M Sell
310,969
-247,985
-44% -$67.9M 0.02% 761
2021
Q4
$176M Sell
558,954
-69,525
-11% -$20M 0.04% 395
2021
Q3
$177M Buy
628,479
+105,499
+20% +$30.9M 0.04% 393
2021
Q2
$144M Sell
522,980
-139,342
-21% -$37M 0.03% 483
2021
Q1
$169M Buy
662,322
+444,502
+204% +$104M 0.04% 353
2020
Q4
$44.3M Sell
217,820
-342,661
-61% -$68.9M 0.01% 1047
2020
Q3
$106M Sell
560,481
-410,870
-42% -$75.8M 0.03% 435
2020
Q2
$161M Buy
971,351
+881,644
+983% +$142M 0.06% 234
2020
Q1
$11.3M Buy
89,707
+31,289
+54% +$5.25M 0.01% 1728
2019
Q4
$9.9M Sell
58,418
-465,649
-89% -$78.3M ﹤0.01% 2209
2019
Q3
$88M Sell
524,067
-338,985
-39% -$57.6M 0.04% 457
2019
Q2
$149M Buy
863,052
+114,014
+15% +$18.5M 0.07% 247
2019
Q1
$115M Buy
749,038
+371,630
+98% +$53.3M 0.06% 313
2018
Q4
$47.7M Buy
377,408
+181,227
+92% +$28.3M 0.03% 651
2018
Q3
$34.1M Buy
196,181
+192,860
+5,807% +$34.1M 0.02% 993
2018
Q2
$596K Sell
3,321
-115,528
-97% -$20.3M ﹤0.01% 6083
2018
Q1
$19.2M Sell
118,849
-19,952
-14% -$3.41M 0.01% 1149
2017
Q4
$22.1M Sell
138,801
-276,929
-67% -$42.6M 0.01% 1101
2017
Q3
$62.8M Sell
415,730
-15,681
-4% -$2.43M 0.05% 429
2017
Q2
$66.5M Buy
431,411
+195,990
+83% +$27.9M 0.06% 374
2017
Q1
$33.8M Buy
235,421
+218,816
+1,318% +$30.2M 0.03% 643
2016
Q4
$2.13M Buy
+16,605
New +$2.15M ﹤0.01% 2877
2016
Q3
– Sell
-58,411
Closed -$8.01M – 7500
2016
Q2
$7.61M Buy
58,411
+22,586
+63% +$2.83M 0.01% 1501
2016
Q1
$4.2M Buy
35,825
+28,836
+413% +$3.22M 0.01% 1977
2015
Q4
$864K Sell
6,989
-186,949
-96% -$22.4M ﹤0.01% 3878
2015
Q3
$21M Buy
193,938
+121,985
+170% +$14.7M 0.02% 869
2015
Q2
$8.72M Buy
71,953
+26,969
+60% +$3.27M 0.01% 1591
2015
Q1
$5.67M Buy
44,984
+18,833
+72% +$2.25M 0.01% 1937
2014
Q4
$2.82M Sell
26,151
-695,391
-96% -$71.5M ﹤0.01% 2609
2014
Q3
$73.4M Buy
721,542
+464,619
+181% +$48.9M 0.08% 258
2014
Q2
$26.3M Buy
256,923
+196,895
+328% +$19.9M 0.03% 669
2014
Q1
$5.9M Buy
60,028
+7,130
+13% +$662K 0.01% 1663
2013
Q4
$4.83M Sell
52,898
-88,117
-62% -$8.75M 0.01% 1720
2013
Q3
$14M Sell
141,015
-42,434
-23% -$4.16M 0.02% 908
2013
Q2
$18.4M Hold
183,449
– – 0.03% 701

Other funds holding LH

Ken Griffin's LH Position: Q3 2026 in Review

Ken Griffin increased its Labcorp (LH) stake by 650% in Q3 2026, buying an estimated $71.3M and bringing the position to 265,420 shares worth $81.8M. The position accounts for 0.01% of the portfolio, ranked #1130.

Ken Griffin first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $328M in Q4 2024. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Ken Griffin held 265,420 shares of Labcorp worth $81.8M as of Q3 2026.
  • Ken Griffin bought 230,053 Labcorp shares in Q3 2026, an estimated $71.3M.
  • Labcorp made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1130 holding.
  • Ken Griffin first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Ken Griffin's Labcorp position peaked at $328M in Q4 2024.
  • 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.